Massmutual Trust CO Fsb Xenon Pharmaceuticals Inc. Transaction History
Massmutual Trust CO Fsb
- $3.4 Billion
- Q1 2025
A detailed history of Massmutual Trust CO Fsb transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 39 shares of XENE stock, worth $1,336. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39Holding current value
$1,336% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding XENE
# of Institutions
219Shares Held
66.7MCall Options Held
109KPut Options Held
2.1K-
Avoro Capital Advisors LLC New York, NY5.67MShares$194 Million3.24% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.52MShares$155 Million1.73% of portfolio
-
Braidwell LP Stamford, CT2.91MShares$99.8 Million6.4% of portfolio
-
Janus Henderson Group PLC London, X02.87MShares$98.2 Million0.06% of portfolio
-
Commodore Capital LP New York, NY2.74MShares$93.9 Million10.76% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.13B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...